You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
可孚醫療(301087.SZ):2022年公司自產產品收入佔比例超50%
格隆匯 06-13 09:09

格隆匯6月13日丨可孚醫療(301087.SZ)接受機構調研、現場參觀,就“公司自有品牌自產、自有品牌外購和代理品牌的比例是多少?”

公司回覆稱,近年來,公司不斷加大對技術研發、生產場地、機器設備和人員的投入,提高了自產產品的種類和產能。2022年公司自產產品收入佔比例超50%,自有品牌收入佔比超80%,血壓計、血糖儀、體温計、輪椅、護理牀、製氧機等核心產品實現自主生產。目前代理產品主要包括呼吸機、理療儀和助聽器等。近兩年自產比例雖然提升不大,但是公司產品結構一直在調整和優化。隨着長沙和湘陰新生產基地的陸續投產,公司將循序漸進地擴大生產產能、豐富自產產品品類,提升生產的自動化和信息化水平,通過實施精細化生產管理和個性化產品的定製生產,逐步形成生產能力穩定、生產成本可控、生產質量精湛的精益管理生產體系。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account